Safety and tolerability of combining CGRP monoclonal antibodies with Gepants in patients with migraine: a retrospective study

被引：0
|
作者：
Alsaadi, T. [1 ]
Santos, V. [1 ]
Al Qaissi, I. [1 ]
Aldaher, B. [1 ]
Al Fardan, A. [1 ]
Bader, Y. [1 ]
Suliman, R. [1 ]
机构：
[1] Amer Ctr Psychiat & Neurol, Neurol, Abu Dhabi, U Arab Emirates
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
AL015
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
    Alsaadi, Taoufik
    Suliman, Reem
    Santos, Vanessa
    Al Qaisi, Ibrahim
    Carmina, Princess
    Aldaher, Batool
    Haddad, Shadi
    Bader, Yazan
    [J]. NEUROLOGY AND THERAPY, 2024, 13 (02) : 465 - 473
  • [2] Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
    Taoufik Alsaadi
    Reem Suliman
    Vanessa Santos
    Ibrahim Al Qaisi
    Princess Carmina
    Batool Aldaher
    Shadi Haddad
    Yazan Bader
    [J]. Neurology and Therapy, 2024, 13 : 465 - 473
  • [3] Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
    Messina, Roberta
    Huessler, Eva-Maria
    Puledda, Francesca
    Haghdoost, Faraidoon
    Lebedeva, Elena R.
    Diener, Hans-Christoph
    [J]. CEPHALALGIA, 2023, 43 (03)
  • [4] Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice: A Retrospective Cohort Study
    Alex, Ashley
    Vaughn, Caila
    Rayhill, Melissa
    [J]. HEADACHE, 2020, 60 (10): : 2454 - 2462
  • [5] Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants
    Do, T. P.
    Al-Saoudi, A.
    Ashina, M.
    [J]. REVUE NEUROLOGIQUE, 2021, 177 (07) : 827 - 833
  • [6] Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials
    Silvestro, Marcello
    Orologio, Ilaria
    Siciliano, Mattia
    Trojsi, Francesca
    Tessitore, Alessandro
    Tedeschi, Gioacchino
    Russo, Antonio
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2023, 28 (02) : 79 - 96
  • [7] Safety concerns of treatment with anti-CGRP monoclonal antibodies in patients with migraine
    van der Arend, Britt W. H.
    van Veelen, Nancy
    de Ruijter, Joelle E. T.
    Olsen, Michael H.
    van den Brink, Antoinette Maassen
    Terwindt, Gisela M.
    [J]. CEPHALALGIA, 2023, 43 (1supp) : 233 - 233
  • [8] Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
    Charleston, Larry
    Talon, Brian
    Sullivan, Christine
    Anderson, Carlton
    Kymes, Steven
    Regnier, Stephane A. A.
    Soni-Brahmbhatt, Seema
    Nahas, Stephanie J. J.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [9] Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
    Larry Charleston
    Brian Talon
    Christine Sullivan
    Carlton Anderson
    Steven Kymes
    Stephane A. Regnier
    Seema Soni-Brahmbhatt
    Stephanie J. Nahas
    [J]. The Journal of Headache and Pain, 24
  • [10] Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients
    Schweiger, Vittorio
    Bellamoli, Paola
    Taus, Francesco
    Gottin, Leonardo
    Martini, Alvise
    Nizzero, Marta
    Bonora, Eleonora
    Del Balzo, Giovanna
    Donadello, Katia
    Secchettin, Erica
    Finco, Gabriele
    De Santis, Daniele
    Polati, Enrico
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
12345